COASTAL FINANCIAL (NASDAQ: CCB) INVESTOR ALERT: HAGENS BERMAN ENCOURAGES CCB INVESTORS WITH SUBSTANTIAL LOSSES TO CONTACT FIRM BEFORE DECEMBER 1 DEADLINE IN SECURITIES CLASS ACTION

Coastal Financial reported a $42.1 million GAAP net loss for Q2 2026, including $68.8 million in credit expense tied to a single CCBX partner relationship. Its shares fell $30.75, or 43.5%, to $39.91 on July 30, 2026, after the results; a pending securities class action alleges the company misrepresented CCBX credit quality and risk controls. Investors seeking lead-plaintiff appointment must act by Dec. 1, 2026.

Analysis

The incremental signal is not the lead-plaintiff deadline; it is whether the reported partner-linked loss exposes a repeatable weakness in CCB’s BaaS risk-transfer model. The complaint’s claims remain allegations, but the reported credit charge makes partner concentration, underwriting oversight, and the realizable value of credit enhancements the key diligence questions. If protections prove less effective than investors assumed, the risk is not limited to one quarter: tighter partner screening and higher monitoring costs could constrain CCBX growth, while a broader retreat by banks from BaaS could shift activity toward better-capitalized or more tightly controlled providers.

Near term (days to weeks), this law-firm notice itself is unlikely to add much information after the sharp repricing; avoid treating it as a fresh fundamental catalyst. Over 1–3 months, further disclosures on the partner exposure, recoveries, reserve adequacy, and control remediation matter more than litigation milestones. Over 6–18 months, the structural question is whether CCB can grow the segment without accepting concentrated, hard-to-value counterparty risk. The bearish case is falsified by credible evidence that the charge is isolated, enhancement assets are recoverable, and subsequent credit performance and partner concentration improve. Conversely, additional partner-related provisions or weaker-than-expected recoveries would strengthen it. Litigation outcomes are long-dated and uncertain; do not equate an allegation with liability.

Key Decisions for Investors

• No trade on the legal notice alone. Keep CCB underweight/watch pending the next filing or earnings disclosure that quantifies remaining partner exposure, credit-enhancement recoverability, and CCBX concentration; these are the missing inputs needed to assess residual downside.
• For portfolios requiring exposure, consider a small relative-value position: short CCB against a diversified bank-sector proxy such as KRE, rather than a large outright short. The thesis is company-specific risk repricing; the main risk is a broad bank selloff or rapid CCB stabilization. Reassess if CCBX credit costs normalize and the stock persistently outperforms the proxy alongside evidence of recoveries and stronger controls.
• Track over the next 1–3 months: additional provisions or write-downs tied to the same or other partners, revised credit-risk disclosures, and management’s remediation and growth plans. Any new loss would support the underweight; demonstrated recoveries with no repeat exposure would weaken it.
• Do not infer broad BaaS contagion from one partner relationship. Monitor whether other bank/platform providers report tighter onboarding, slower partner growth, or higher compliance costs; absent corroboration, avoid a sector-wide short.